SCHEMBL277501

SCHEMBL277501

CC(C)N(CN(C(C)C)C(C)C)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15147833 0.81 MEN1 (0.38) MEN1KMT2A
SCHEMBL15743714 0.78 MEN1 (0.36) MEN1KMT2A
SCHEMBL1133203 0.73 MEN1 (0.62) MEN1KMT2A
SCHEMBL27356321 0.70 MEN1 (0.50) MEN1KMT2A
SCHEMBL12790383 0.70 TSHR (0.39) MEN1KMT2A
SCHEMBL3165905 0.70 TSHR (0.39) MEN1KMT2A
SCHEMBL17426949 0.70 TSHR (0.39) MEN1KMT2A
SCHEMBL1746 0.70
SCHEMBL5544690 0.70 MEN1 (0.42) MEN1KMT2A
SCHEMBL7097725 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0302183-A2 Hybrid corn seed and method CHEMBRED, INC. (US) 1989-02-08 EP claimed
US-20260090293-A1 SEMICONDUCTOR STACKS AND PROCESSES THEREOF LAM RES CORP (US) 2026-03-26 US disclosed
US-12568781-B2 Selective silicon trim by thermal etching LAM RESEARCH CORPORATION (US) 2026-03-03 US disclosed
WO-2026044028-A1 APPARATUSES AND TECHNIQUES FOR THERMAL ETCHING LAM RESEARCH CORPORATION (US) 2026-02-26 WO disclosed
US-20260052923-A1 SELECTIVE SIGE ETCHING USING THERMAL F2 WITH ADDITIVE LAM RES CORP (US) 2026-02-19 US disclosed
US-20260026274-A1 IN SITU DECLOGGING IN PLASMA ETCHING LAM RES CORP (US) 2026-01-22 US disclosed
WO-2025235908-A1 PASSIVATION FOR ETCHING OF SEMICONDUCTOR MATERIALS WITH SEAM-LIKE DEFECTS LAM RESEARCH CORPORATION (US) 2025-11-13 WO disclosed
EP-4591341-A1 SEMICONDUCTOR STACKS AND PROCESSES THEREOF LAM Research Corporation (US) 2025-07-30 EP disclosed
US-20250226233-A1 IN SITU DECLOGGING IN PLASMA ETCHING LAM RESEARCH CORPORATION 2025-07-10 US disclosed
US-20250183051-A1 SELECTIVE PRECISION ETCHING OF SEMICONDUCTOR MATERIALS LAM RESEARCH CORPORATION 2025-06-05 US disclosed
US-20130053566-A1 CATIONIC PALLADIUM COMPLEXES COMPRISING DIAMINO CARBENE LIGANDS AND THEIR USE IN CATALYSIS KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2013-02-28 US disclosed
US-20120323008-A1 GROUP 11 MONO-METALLIC PRECURSOR COMPOUNDS AND USE THEREOF IN METAL DEPOSITION GREENCENTRE CANADA 2012-12-20 US disclosed
US-20120323008-A1 GROUP 11 MONO-METALLIC PRECURSOR COMPOUNDS AND USE THEREOF IN METAL DEPOSITION GREENCENTRE CANADA 2012-12-20 US disclosed
US-8134005-B2 Preparation and use of magnesium amides Ludwig-Maximilians-Universitat München (DE) 2012-03-13 US disclosed
US-20100144516-A1 PREPARATION AND USE OF MAGNESIUM AMIDES LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2010-06-10 US disclosed
US-20090176988-A1 Preparation and Use of Magnesium Amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUENCHEN (DE) 2009-07-09 US disclosed
US-4804405-A DIAMINOMETHANE DERIVATIVE; OPTIONAL ANTIDOTE ESZAKMAGYARORSZAGI VEGYIMUVEK (HU) 1989-02-14 US disclosed
US-4394312-A Process for preparing rifamycin derivatives KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 1983-07-19 US disclosed
US-3957761-A Process for the production of 1-aminomethyl-6-phenyl-4h-s-triazolo-[4,3-a][1]benzodiazepines and intermediates THE UPJOHN COMPANY (US) 1976-05-18 US disclosed
US-3933816-A 3-(Substituted aminomethyl)-7-substituted-3,5-dihydro-as-triazino[4,3-a][1,5]benzodiazepines THE UPJOHN COMPANY (US) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053566-A1 CATIONIC PALLADIUM COMPLEXES COMPRISING DIAMINO CARBENE LIGANDS AND THEIR USE IN CATALYSIS MLX, LBR, LRRK2 MEN1 2931/4885KMT2A 351/4885
US-12568781-B2 Selective silicon trim by thermal etching TRIM4, NOX3, NOS3 MEN1 3872/4885KMT2A 1877/4885
US-20260052923-A1 SELECTIVE SIGE ETCHING USING THERMAL F2 WITH ADDITIVE STIM2, AFF2, AFF4 MEN1 2860/4885KMT2A 3231/4885
US-20260090293-A1 SEMICONDUCTOR STACKS AND PROCESSES THEREOF PRPF3, PRPF4, MTREX MEN1 1923/4885KMT2A 1083/4885
US-20120323008-A1 GROUP 11 MONO-METALLIC PRECURSOR COMPOUNDS AND USE THEREOF IN METAL DEPOSITION DACH1, AOC1, DDT MEN1 216/4885KMT2A 1788/4885
US-20090176988-A1 Preparation and Use of Magnesium Amides MLX, GLRX3, SFXN3 MEN1 1804/4885KMT2A 1480/4885
US-20260026274-A1 IN SITU DECLOGGING IN PLASMA ETCHING CTCF, EPCAM, CDH1 MEN1 1386/4885KMT2A 2723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.